Do analysts prefer SERA or CCM?

Sera Prognostics presently has a consensus target price of $5.50, indicating a potential upside of 194.12%. Given Sera Prognostics' stronger consensus rating and higher possible upside, research analysts clearly believe Sera Prognostics is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sera Prognostics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, SERA or CCM?

Concord Medical Services has higher revenue and earnings than Sera Prognostics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sera Prognostics $57K 1,284.69 -$31.93M -$0.65 N/A Concord Medical Services $65.85M 0.29 -$13.27M N/A N/A

Does the media prefer SERA or CCM?

In the previous week, Sera Prognostics had 2 more articles in the media than Concord Medical Services. MarketBeat recorded 5 mentions for Sera Prognostics and 3 mentions for Concord Medical Services. Concord Medical Services' average media sentiment score of 0.22 beat Sera Prognostics' score of 0.15 indicating that Concord Medical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sera Prognostics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer DCGO or CCM?

DocGo currently has a consensus price target of $2.38, suggesting a potential upside of 309.77%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts clearly believe DocGo is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, DCGO or CCM?

Concord Medical Services has lower revenue, but higher earnings than DocGo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $301.71M 0.19 -$182.40M -$1.91 N/A Concord Medical Services $65.85M 0.29 -$13.27M N/A N/A

Does the media refer more to DCGO or CCM?

In the previous week, DocGo and DocGo both had 3 articles in the media. DocGo's average media sentiment score of 0.39 beat Concord Medical Services' score of 0.22 indicating that DocGo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate CCM or EUDA?

EUDA Health has a consensus target price of $55.00, indicating a potential upside of 261.84%. Given EUDA Health's stronger consensus rating and higher probable upside, analysts plainly believe EUDA Health is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, CCM or EUDA?

EUDA Health has lower revenue, but higher earnings than Concord Medical Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Concord Medical Services $65.85M 0.29 -$13.27M N/A N/A EUDA Health $6.82M 6.66 -$2.77M -$2.40 N/A

Is CCM or EUDA more profitable?

Company Net Margins Return on Equity Return on Assets Concord Medical Services N/A N/A N/A EUDA Health N/A N/A N/A

Does the media favor CCM or EUDA?

In the previous week, Concord Medical Services had 1 more articles in the media than EUDA Health. MarketBeat recorded 3 mentions for Concord Medical Services and 2 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.67 beat Concord Medical Services' score of 0.22 indicating that EUDA Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Concord Medical Services 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend MRAI or CCM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, MRAI or CCM?

Concord Medical Services has higher revenue and earnings than Marpai. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Marpai $34.87M 0.42 -$28.75M -$0.87 N/A Concord Medical Services $65.85M 0.29 -$13.27M N/A N/A

Is MRAI or CCM more profitable?

Concord Medical Services has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Company Net Margins Return on Equity Return on Assets Marpai -85.70% N/A -100.23% Concord Medical Services N/A N/A N/A

Do analysts recommend BMGL or CCM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, BMGL or CCM?

Basel Medical Group has higher earnings, but lower revenue than Concord Medical Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Basel Medical Group $11.32M 0.98 -$9.50M N/A N/A Concord Medical Services $65.85M 0.29 -$13.27M N/A N/A

Is BMGL or CCM more profitable?

Company Net Margins Return on Equity Return on Assets Basel Medical Group N/A N/A N/A Concord Medical Services N/A N/A N/A

Does the media favor BMGL or CCM?

In the previous week, Basel Medical Group had 5 more articles in the media than Concord Medical Services. MarketBeat recorded 8 mentions for Basel Medical Group and 3 mentions for Concord Medical Services. Basel Medical Group's average media sentiment score of 0.23 beat Concord Medical Services' score of 0.22 indicating that Basel Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Basel Medical Group 0 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Concord Medical Services (CCM) Competitors

$4.53 +0.12 (+2.70%)

As of 06/12/2026 04:00 PM Eastern

Compare

CCM vs. SERA, DCGO, EUDA, MRAI, and BMGL

Should you buy Concord Medical Services stock or one of its competitors? MarketBeat compares Concord Medical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Concord Medical Services include Sera Prognostics (SERA), DocGo (DCGO), EUDA Health (EUDA), Marpai (MRAI), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry.

How does Concord Medical Services compare to Sera Prognostics?

Sera Prognostics (NASDAQ:SERA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

Sera Prognostics presently has a consensus target price of $5.50, indicating a potential upside of 194.12%. Given Sera Prognostics' stronger consensus rating and higher possible upside, research analysts clearly believe Sera Prognostics is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sera Prognostics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Sera Prognostics has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.99, indicating that its stock price is 199% less volatile than the broader market.

54.6% of Sera Prognostics shares are held by institutional investors. 11.3% of Sera Prognostics shares are held by company insiders. Comparatively, 46.5% of Concord Medical Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Sera Prognostics had 2 more articles in the media than Concord Medical Services. MarketBeat recorded 5 mentions for Sera Prognostics and 3 mentions for Concord Medical Services. Concord Medical Services' average media sentiment score of 0.22 beat Sera Prognostics' score of 0.15 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sera Prognostics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Concord Medical Services has a net margin of 0.00% compared to Sera Prognostics' net margin of -56,385.97%. Concord Medical Services' return on equity of 0.00% beat Sera Prognostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sera Prognostics	-56,385.97%	-41.02%	-30.95%
Concord Medical Services	N/A	N/A	N/A

Concord Medical Services has higher revenue and earnings than Sera Prognostics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sera Prognostics	$57K	1,284.69	-$31.93M	-$0.65	N/A
Concord Medical Services	$65.85M	0.29	-$13.27M	N/A	N/A

Summary

Sera Prognostics beats Concord Medical Services on 8 of the 15 factors compared between the two stocks.

How does Concord Medical Services compare to DocGo?

DocGo (NASDAQ:DCGO) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

DocGo currently has a consensus price target of $2.38, suggesting a potential upside of 309.77%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts clearly believe DocGo is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

DocGo has a beta of 1, suggesting that its stock price has a similar volatility profile to the broader market.Comparatively, Concord Medical Services has a beta of -0.99, suggesting that its stock price is 199% less volatile than the broader market.

56.4% of DocGo shares are owned by institutional investors. 3.8% of DocGo shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, DocGo and DocGo both had 3 articles in the media. DocGo's average media sentiment score of 0.39 beat Concord Medical Services' score of 0.22 indicating that DocGo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Concord Medical Services has a net margin of 0.00% compared to DocGo's net margin of -62.23%. Concord Medical Services' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-62.23%	-44.09%	-29.14%
Concord Medical Services	N/A	N/A	N/A

Concord Medical Services has lower revenue, but higher earnings than DocGo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$301.71M	0.19	-$182.40M	-$1.91	N/A
Concord Medical Services	$65.85M	0.29	-$13.27M	N/A	N/A

Summary

DocGo beats Concord Medical Services on 7 of the 13 factors compared between the two stocks.

How does Concord Medical Services compare to EUDA Health?

Concord Medical Services (NYSE:CCM) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

In the previous week, Concord Medical Services had 1 more articles in the media than EUDA Health. MarketBeat recorded 3 mentions for Concord Medical Services and 2 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.67 beat Concord Medical Services' score of 0.22 indicating that EUDA Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Concord Medical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

4.4% of EUDA Health shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

EUDA Health has a consensus target price of $55.00, indicating a potential upside of 261.84%. Given EUDA Health's stronger consensus rating and higher probable upside, analysts plainly believe EUDA Health is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Concord Medical Services	N/A	N/A	N/A
EUDA Health	N/A	N/A	N/A

Concord Medical Services has a beta of -0.99, indicating that its share price is 199% less volatile than the broader market. Comparatively, EUDA Health has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

EUDA Health has lower revenue, but higher earnings than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concord Medical Services	$65.85M	0.29	-$13.27M	N/A	N/A
EUDA Health	$6.82M	6.66	-$2.77M	-$2.40	N/A

Summary

EUDA Health beats Concord Medical Services on 8 of the 11 factors compared between the two stocks.

How does Concord Medical Services compare to Marpai?

Marpai (NASDAQ:MRAI) and Concord Medical Services (NYSE:CCM) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Concord Medical Services had 3 more articles in the media than Marpai. MarketBeat recorded 3 mentions for Concord Medical Services and 0 mentions for Marpai. Concord Medical Services' average media sentiment score of 0.22 beat Marpai's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
Marpai	Neutral
Concord Medical Services	Neutral

Concord Medical Services has a net margin of 0.00% compared to Marpai's net margin of -85.70%.

Company	Net Margins	Return on Equity	Return on Assets
Marpai	-85.70%	N/A	-100.23%
Concord Medical Services	N/A	N/A	N/A

Marpai has a beta of 4.94, meaning that its stock price is 394% more volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.99, meaning that its stock price is 199% less volatile than the broader market.

Concord Medical Services has higher revenue and earnings than Marpai.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$34.87M	0.42	-$28.75M	-$0.87	N/A
Concord Medical Services	$65.85M	0.29	-$13.27M	N/A	N/A

49.8% of Marpai shares are owned by institutional investors. 46.1% of Marpai shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Concord Medical Services beats Marpai on 8 of the 11 factors compared between the two stocks.

How does Concord Medical Services compare to Basel Medical Group?

Basel Medical Group (NASDAQ:BMGL) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Basel Medical Group has higher earnings, but lower revenue than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$11.32M	0.98	-$9.50M	N/A	N/A
Concord Medical Services	$65.85M	0.29	-$13.27M	N/A	N/A

In the previous week, Basel Medical Group had 5 more articles in the media than Concord Medical Services. MarketBeat recorded 8 mentions for Basel Medical Group and 3 mentions for Concord Medical Services. Basel Medical Group's average media sentiment score of 0.23 beat Concord Medical Services' score of 0.22 indicating that Basel Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Basel Medical Group	0 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Basel Medical Group has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.99, suggesting that its stock price is 199% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Concord Medical Services	N/A	N/A	N/A

Summary

Basel Medical Group beats Concord Medical Services on 5 of the 6 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCM vs. The Competition

Export

Metric	Concord Medical Services	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$19.17M	$3.76B	$6.52B	$23.31B
Dividend Yield	N/A	0.73%	2.67%	4.05%
P/E Ratio	N/A	12.36	24.00	31.31
Price / Sales	0.29	1.26	515.84	100.04
Price / Cash	2.37	18.08	27.48	18.65
Price / Book	0.07	2.27	10.60	4.69
Net Income	-$13.27M	$47.01M	$3.57B	$1.08B
7 Day Performance	-6.93%	1.60%	0.59%	2.07%
1 Month Performance	-16.05%	-6.86%	1.54%	3.44%
1 Year Performance	-32.84%	38.38%	25.41%	24.11%

Concord Medical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCM Concord Medical Services	0.5092 of 5 stars	$4.42 +0.1%	N/A	-32.8%	$19.17M	$65.85M	N/A	970	Gap Up
SERA Sera Prognostics	3.6102 of 5 stars	$2.05 +0.5%	$5.00 +143.9%	+9.4%	$79.88M	$80K	N/A	120
DCGO DocGo	3.489 of 5 stars	$0.57 -8.4%	$2.38 +313.5%	-60.0%	$61.94M	$322.20M	N/A	3,568	Gap Down
EUDA EUDA Health	2.3189 of 5 stars	$16.75 -0.2%	$55.00 +228.4%	-79.5%	$50.28M	$6.82M	N/A	2
MRAI Marpai	N/A	$0.53 -18.5%	N/A	-59.0%	$13.43M	$34.87M	N/A	150	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CCM) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concord Medical Services (CCM) Competitors

CCM vs. SERA, DCGO, EUDA, MRAI, and BMGL

How does Concord Medical Services compare to Sera Prognostics?

Summary

How does Concord Medical Services compare to DocGo?

Summary

How does Concord Medical Services compare to EUDA Health?

Summary

How does Concord Medical Services compare to Marpai?

Summary

How does Concord Medical Services compare to Basel Medical Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concord Medical Services (CCM) Competitors

CCM vs. SERA, DCGO, EUDA, MRAI, and BMGL

How does Concord Medical Services compare to Sera Prognostics?

Do analysts prefer SERA or CCM?

Which has more risk & volatility, SERA or CCM?

Do insiders and institutionals believe in SERA or CCM?

Does the media prefer SERA or CCM?

Is SERA or CCM more profitable?

Which has preferable valuation and earnings, SERA or CCM?

Summary

How does Concord Medical Services compare to DocGo?

Do analysts prefer DCGO or CCM?

Which has more volatility & risk, DCGO or CCM?

Do institutionals & insiders have more ownership in DCGO or CCM?

Does the media refer more to DCGO or CCM?

Is DCGO or CCM more profitable?

Which has higher valuation & earnings, DCGO or CCM?

Summary

How does Concord Medical Services compare to EUDA Health?

Does the media favor CCM or EUDA?

Do institutionals and insiders believe in CCM or EUDA?

Do analysts rate CCM or EUDA?

Is CCM or EUDA more profitable?

Which has more volatility and risk, CCM or EUDA?

Which has higher earnings and valuation, CCM or EUDA?

Summary

How does Concord Medical Services compare to Marpai?

Do analysts recommend MRAI or CCM?

Does the media refer more to MRAI or CCM?

Is MRAI or CCM more profitable?

Which has more volatility and risk, MRAI or CCM?

Which has better earnings and valuation, MRAI or CCM?

Do insiders & institutionals have more ownership in MRAI or CCM?

Summary

How does Concord Medical Services compare to Basel Medical Group?

Do analysts recommend BMGL or CCM?

Which has better valuation & earnings, BMGL or CCM?

Does the media favor BMGL or CCM?

Which has more risk & volatility, BMGL or CCM?

Is BMGL or CCM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools